(Press-News.org) Denver, Colo. ― Anemia during pregnancy is a common occurrence and often due to iron deficiency. It is a global public health problem, affecting an estimated 37 percent of pregnant individuals, according to the World Health Organization. Iron deficiency anemia is associated with increased rates of pregnancy-related problems, such as going into labor prematurely, hemorrhaging and, in some cases, even death. For the infant, maternal iron deficiency also can have long-term implications on their overall health and development.
Current obstetric guidelines recommend that pregnant people who suffer from iron deficiency anemia take daily oral iron supplements and, in cases of persistent iron deficiency anemia, they may be administered iron intravenously, commonly in the third trimester. Nonetheless, anemia during pregnancy remains a global health problem.
In a new study to be presented today at the Society for Maternal-Fetal Medicine’s (SMFM) annual meeting, The Pregnancy Meeting™ researchers will unveil findings from a clinical trial in India that suggest that a single dose of iron delivered intravenously early in the second trimester is a safe and effective intervention for anemia during pregnancy.
The study was conducted across multiple sites in India and involved a total of 4,368 participants, making it one of the largest studies to date employing IV iron in pregnancy. India was selected because of the prevalence of anemia in the country, according to the study’s lead author, Richard Derman, MD, MPH, vice provost of global affairs and professor of obstetrics and gynecology at Thomas Jefferson University in Philadelphia.
Participants identified to have moderate anemia and iron deficiency prior to 17 weeks’ gestation were randomized into three groups. The first cohort received the current standard of care — daily oral iron supplementation. The second and third groups received two commonly used IV iron formulations for single dose infusion, and the only ones approved for use in India, ferric carboxymaltose (FCM) and ferric derisomaltose (FDM). The two primary outcomes researchers looked at were differences in the IV iron groups compared to oral iron in: 1) rate of low birthweight infants and 2) rate of participants who reverted to a non-anemic state by delivery.
Results found that while all three groups had achieved similar rates of “non-anemic status” (normal blood counts) at the time of delivery, those who received IV iron had significantly lower rates of needing additional non-study IV iron or a blood transfusion prior to delivery. In the FCM IV iron cohort, results showed a reduced incidence of low birthweight infants compared to oral iron.
“What’s unique about this study is that we did the iron intervention early in the second trimester. Many other studies comparing IV iron to oral iron are initiated in the third trimester,” says study co-author Rupsa C. Boelig, MD, MS, a maternal-fetal medicine subspecialist and associate professor at Thomas Jefferson University’s Sidney Kimmel Medical College. Boelig also serves as director of the University’s Department of Obstetrics and Gynecology Research Unit and associate director for the Maternal Fetal Medicine Fellowship.
“Iron requirements increase dramatically during pregnancy. An additional 1 gram of iron is required for the developing fetus, and for placental storage. Such requirements increased dramatically during the second and trimester, so it’s much more difficult to catch-up if you’re intervening in the third trimester,” notes Boelig. “Studies have shown that maternal iron deficiency anemia early in pregnancy is most strongly correlated with adverse outcomes, including short-term infant outcomes such as low birthweight and longer-term childhood outcomes, including autism and schizophrenia. So there is a need to intervene earlier and aggressively address anemia.
“From this trial it is evident that single dose IV iron preparations are safe and easy to administer under proper supervision and facilities in order to treat anemia in pregnancy,” says Mrutyunjaya B. Bellad, MD, professor in the Department of Obstetrics and Gynecology at the KLE Academy of Higher Education and Research, J.N. Medical College in Belagavi, India. “We are immensely thankful to the pregnant women who participated in this trial for the benefit of the global pregnant women. We hope this should end the menace of anemia related complications. We thank all those who have contributed to this successful trial.”
Researchers believe that new clinical guidelines should address the potential benefit of single dose IV iron as a primary treatment for moderate anemia due to iron deficiency during pregnancy.
The abstract was published in the January 2025 issue of Pregnancy, a new open-access journal and the first official journal for the Society for Maternal-Fetal Medicine. The full article is scheduled to be published in the American Journal of Obstetrics and Gynecology.
This study was funded by the Children’s Investment Fund Foundation (CIFF).
Additional news releases about select SMFM research being presented are posted on AAAS’s EurekAlert (subscription needed) approximately one week in advance of embargo lifting. Embargoes lift on the date and start time of the abstract presentation.
Disclosure Statement
Richard Derman has received grant support from the National Institutes of Health, the Foundation for the National Institutes of Health, Children’s Investment Fund Foundation, Bill and Melinda Gates Foundation, and Thrasher Foundation.
Rupsa Boelig received grant support from the Children’s Investment Fund Foundation (CIFF). She also received grant support from the Bill and Melinda Gates Foundation (BMGF) for a study on postpartum IV iron, where she serves as a co-investigator. She has received the COVIS Pharma Investigator Sponsored Research Award for a study on early antenatal support for IDA in pregnancy: a randomized controlled trial (that IV iron formulation is ferumoxytol, not studied in this manuscript). Additionally, she received the Pharmacosmos Investigator Sponsored Research Award for 2022-2023 to explore the impact of maternal anemia on COVID-19 immunity.
# # #
About the Society for Maternal-Fetal Medicine
The Society for Maternal-Fetal Medicine (SMFM), founded in 1977, is the medical professional society for obstetricians who have additional training in high-risk, complicated pregnancies. SMFM represents more than 7,000 members who care for high-risk pregnant people and provides education, promotes research, and engages in advocacy to reduce disparities and optimize the health of high-risk pregnant people and their families. SMFM and its members are dedicated to optimizing maternal and fetal outcomes and assuring medically appropriate treatment options are available to all patients. For more information, visit SMFM.org and connect with the organization on Facebook, X, and Instagram. For the latest 2025 Annual Meeting news and updates, follow the hashtag #SMFM25.
END
CLEVELAND—Psoriasis, a painful and uncomfortable inflammatory skin condition that affects millions worldwide, flares up from the activity of disease- and infection-protecting immune cells.
In a new study, researchers at Case Western Reserve University School of Medicine have determined that a protein called NF-kB c-Rel can intensify the condition’s symptoms when activated by signals from the body’s immune system. Understanding how “c-Rel” affects skin inflammation could lead to new treatments, they said.
The study, published recently in eBioMedicine, examined how ...
MINNEAPOLIS/ST. PAUL (01/31/2025) — Portable MRI (pMRI) technologies are rapidly transforming the landscape of neuroscience research, allowing neuroscientists to acquire brain data in community settings outside the hospital for the first time. But as neuroscientists increase access to MRI technology and move their research from a lab environment to broad community settings, they face novel ethical, legal, and societal issues (ELSI).
To prepare neuroscientists to address these challenges, an interdisciplinary team of scientists, ethicists, and legal experts, supported by an NIH BRAIN Initiative grant, analyzed the issues. The team released the first-ever checklist ...
Leipzig. Over the next few years, climate researchers from Germany aim to achieve a breakthrough in the radiative properties of clouds by describing the corresponding processes not just one-dimensionally, as has been the case up to now, but three-dimensionally in future. Capturing clouds and radiation in 3D is seen as an important step towards undistorted remote sensing of the atmosphere and improved modelling of climate and weather. The new research group of the German Research Foundation (DFG) brings together experts in atmospheric radiation, high-resolution ...
It is well known that consuming sugary drinks increases the risk of diabetes, but the mechanism behind this relationship is unclear. Now, in a paper publishing January 31 in the Cell Press journal Cell Metabolism, researchers show that metabolites produced by gut microbes might play a role. In a long-term cohort of US Hispanic/Latino adults, the researchers identified differences in the gut microbiota and blood metabolites of individuals with a high intake of sugar-sweetened beverages. The altered metabolite profile ...
Researchers from the Tanenbaum group at the Hubrecht Institute have developed a new microscopy technique to observe how ribosomes function in cells. With this method, they can monitor individual ribosomes as they convert mRNA into proteins. The researchers discovered that ribosomes help each other when encountering difficulties, a process they refer to as ‘ribosome cooperativity’. This technique and the findings, published in Cell, provide insights into how proteins are made and offer other researchers a tool to better study mRNA translation.
Our DNA contains genetic information essential for ...
About The Study: This cross-sectional study found that compared with trends from the early 2000s, early adult (ages 25-44) mortality in the U.S. has risen substantially in 2 stages: 2011 to 2019 and 2020 to 2023. Although mortality rates decreased after the core pandemic years, excess mortality remained higher than expected based on pre-pandemic levels. The largest portion of 2023 excess mortality was driven by drug poisoning, but many other external and natural causes exceeded what prior trends would have projected.
Corresponding Author: To contact the corresponding author, Elizabeth Wrigley-Field, PhD, email ewf@umn.edu.
To access the embargoed study: Visit our ...
About The Study: In this cohort study, most patients with overweight or obesity discontinued glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy within 1 year, but those without type 2 diabetes had higher discontinuation rates and lower reinitiation rates. Inequities in access and adherence to effective treatments have the potential to exacerbate disparities in obesity.
Corresponding Author: To contact the corresponding author, Ezekiel J. Emanuel, MD, PhD, email zemanuel@upenn.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2024.57349)
Editor’s ...
About The Study: High ultraprocessed food consumption during early childhood was associated with obesity development, primarily in males in this cohort study of Canadian children. These findings can inform targeted public health initiatives for early childhood centers and caregiver education programs to reduce ultraprocessed food intake and prevent obesity.
Corresponding Author: To contact the corresponding author, Kozeta Miliku, MD, PhD, email kozeta.miliku@utoronto.ca.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2024.57341)
Editor’s Note: Please see the ...
A group of 211 international experts from 79 countries has today published a new framework to facilitate the design, development and implementation of digital health curricula in medical education worldwide.
Published in JAMA Network Open, the Digital Health Competencies in Medical Education (DECODE) framework is designed to help medical institutions better equip future physicians for the ongoing digital transformation in healthcare.
The framework is already beginning to be adopted across the globe, including in the UK where it has influenced ...
Researchers at the University of Toronto are sounding the alarm about the high consumption of ultra-processed foods among preschool-aged children in Canada and its association with obesity development.
“We saw that ultra-processed foods contributed to almost half of a child’s total daily energy intake,” says Kozeta Miliku, assistant professor of nutritional sciences at U of T’s Temerty Faculty of Medicine.
The findings, published today in JAMA Network Open, are the first to describe sex-driven differences in the effects of ultra-processed food on obesity risk among Canadian children, with stronger ...
